HCKK Ventures Ltd
Incorporated in 2017, HCKK Ventures Ltd is in the business of Realty developers, Software consultancy services and dealing in Biomedical Devices
- Market Cap ₹ 47.2 Cr.
- Current Price ₹ 127
- High / Low ₹ 134 / 79.8
- Stock P/E 181
- Book Value ₹ 10.9
- Dividend Yield 0.00 %
- ROCE 1.86 %
- ROE -1.33 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 11.6 times its book value
- Company has a low return on equity of -2.16% over last 3 years.
- Company has high debtors of 279 days.
- Promoter holding has decreased over last 3 years: -6.37%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: IT - Software Industry: Computers - Software - Medium / Small
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.07 | 0.05 | 0.12 | 1.52 | 4.07 | 0.09 | 0.02 | 0.41 | 0.73 | 0.07 | 0.08 | 0.17 | 0.58 | |
0.00 | 0.02 | 0.05 | 1.47 | 4.06 | 0.19 | 0.14 | 0.44 | 0.81 | 0.28 | 0.27 | 0.23 | 0.43 | |
Operating Profit | 0.07 | 0.03 | 0.07 | 0.05 | 0.01 | -0.10 | -0.12 | -0.03 | -0.08 | -0.21 | -0.19 | -0.06 | 0.15 |
OPM % | 100.00% | 60.00% | 58.33% | 3.29% | 0.25% | -111.11% | -600.00% | -7.32% | -10.96% | -300.00% | -237.50% | -35.29% | 25.86% |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.04 | 0.28 | -0.44 | 0.07 | 0.13 | 0.17 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
Profit before tax | 0.07 | 0.03 | 0.06 | 0.04 | 0.01 | -0.09 | -0.12 | 0.01 | 0.19 | -0.66 | -0.13 | 0.07 | 0.32 |
Tax % | 28.57% | 33.33% | 33.33% | 25.00% | 0.00% | 0.00% | 0.00% | -400.00% | 42.11% | 12.12% | 23.08% | 171.43% | |
0.05 | 0.02 | 0.04 | 0.03 | 0.01 | -0.09 | -0.12 | 0.05 | 0.12 | -0.57 | -0.10 | -0.05 | 0.26 | |
EPS in Rs | 2.50 | 1.00 | 1.00 | 0.09 | 0.03 | -0.24 | -0.32 | 0.13 | 0.32 | -1.54 | -0.27 | -0.13 | 0.70 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 53% |
3 Years: | -38% |
TTM: | 1060% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 9% |
TTM: | 253% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 62% |
1 Year: | 20% |
Return on Equity | |
---|---|
10 Years: | -1% |
5 Years: | -1% |
3 Years: | -2% |
Last Year: | -1% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.20 | 0.20 | 0.40 | 3.40 | 3.40 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 |
Reserves | 0.24 | 0.26 | 0.10 | 0.10 | 0.10 | 0.94 | 0.82 | 0.87 | 0.99 | 0.41 | -0.09 | 0.20 | 0.35 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.02 | 0.01 | 0.44 | 0.06 | 0.01 | 0.22 | 0.21 | 0.19 | 0.23 | 0.03 | 0.03 | 0.04 | 0.08 | |
Total Liabilities | 0.46 | 0.47 | 0.94 | 3.56 | 3.51 | 4.87 | 4.74 | 4.77 | 4.93 | 4.15 | 3.65 | 3.95 | 4.14 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.24 | 1.71 | 1.24 | 1.61 | 3.50 | 3.00 |
0.40 | 0.47 | 0.94 | 3.56 | 3.51 | 4.86 | 4.58 | 4.52 | 3.21 | 2.89 | 2.03 | 0.45 | 1.14 | |
Total Assets | 0.46 | 0.47 | 0.94 | 3.56 | 3.51 | 4.87 | 4.74 | 4.77 | 4.93 | 4.15 | 3.65 | 3.95 | 4.14 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | -0.05 | 0.32 | -0.38 | 0.00 | -0.50 | -0.25 | 0.13 | 1.00 | 1.78 | 0.23 | -0.02 | |
0.00 | 0.06 | 0.10 | -1.09 | -1.70 | -0.03 | -0.15 | -0.09 | -1.47 | 0.45 | -0.77 | -1.54 | |
0.00 | 0.00 | -0.06 | 3.00 | 0.00 | 1.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash Flow | 0.00 | 0.01 | 0.36 | 1.53 | -1.70 | 0.71 | -0.40 | 0.04 | -0.47 | 2.23 | -0.55 | -1.55 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 104.29 | 0.00 | 0.00 | 9.61 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 279.12 |
Inventory Days | 0.00 | 0.00 | 649.88 | 486.67 | 486.67 | 0.00 | ||||||
Days Payable | 169.15 | 243.33 | 365.00 | |||||||||
Cash Conversion Cycle | 104.29 | 0.00 | 0.00 | 9.61 | 0.90 | 0.00 | 0.00 | 0.00 | 480.73 | 243.33 | 121.67 | 279.12 |
Working Capital Days | 104.29 | -73.00 | -1,247.08 | 2.40 | 0.90 | 1,703.33 | 10,037.50 | 525.24 | 280.00 | 469.29 | 365.00 | 386.47 |
ROCE % | 16.67% | 6.67% | 12.50% | 2.00% | 0.29% | -2.21% | -2.61% | 0.22% | -1.94% | -4.31% | -3.36% | 1.86% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 1d
- Compliance Certificate As Per Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Period 01St April, 2023 To 31St March, 2024. 12 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
4 Apr - Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations , 2018 for quarter ended on 31st March, 2024
-
Subject: Compliance Certificate- Regulation 7 (3) Of SEBI (LODR) Regulations, 2015.
4 Apr - Compliance Certificate for Regulation 7 (3) of SEBI (LODR), 2015 for the period ended 31st March, 2024
- Closure of Trading Window 29 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Services Offered:[1]
a) Biomedical:[2] Company manufactures, markets and distributes Equilibrium System by Vayu Technology, a patented sports & healthcare solution using wearable sensors and artificial intelligence to optimize performance, prevent injuries and expedite rehabilitation
b) Technology:[3] Software consultancy services to domestic and international companies, mobile and web application development and digital media marketing
c) Construction:[4] Company is planning to launch residential real estate projects